Petros Pharmaceuticals
(NASDAQ:PTPI)
Petros Pharmaceuticals, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Petros Pharmaceuticals, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$0.7798
0.0098[1.27%]
At close: Aug 12
$0.76
-0.0198[-2.54%]
After Hours: 5:16PM EDT
Day High/Low0.75 - 0.79
52 Week High/Low0.65 - 3.62
Open / Close0.79 / 0.78
Float / Outstanding12.8M / 20.7M
Vol / Avg.120.7K / 891.2K
Mkt Cap16.1M
P/E-
50d Avg. Price0.82
Div / Yield-
Payout Ratio-
EPS-0.75
Total Float12.8M

Petros Pharmaceuticals (NASDAQ:PTPI), Quotes and News Summary

Petros Pharmaceuticals (NASDAQ: PTPI)

Day High/Low0.75 - 0.79
52 Week High/Low0.65 - 3.62
Open / Close0.79 / 0.78
Float / Outstanding12.8M / 20.7M
Vol / Avg.120.7K / 891.2K
Mkt Cap16.1M
P/E-
50d Avg. Price0.82
Div / Yield-
Payout Ratio-
EPS-0.75
Total Float12.8M
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Petros Pharmaceuticals Questions & Answers

Q
How do I buy Petros Pharmaceuticals (PTPI) stock?
A

You can purchase shares of Petros Pharmaceuticals (NASDAQ: PTPI) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Petros Pharmaceuticals's (PTPI) competitors?
A

There are no as such competitors for Petros Pharmaceuticals.

Q
What is the target price for Petros Pharmaceuticals (PTPI) stock?
A

The latest price target for Petros Pharmaceuticals (NASDAQ: PTPI) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting PTPI to rise to within 12 months (a possible 412.95% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Petros Pharmaceuticals (PTPI)?
A

The stock price for Petros Pharmaceuticals (NASDAQ: PTPI) is $0.7798 last updated August 12, 2022, 7:56 PM UTC.

Q
Does Petros Pharmaceuticals (PTPI) pay a dividend?
A

The next Petros Pharmaceuticals (PTPI) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Petros Pharmaceuticals (NASDAQ:PTPI) reporting earnings?
A

Petros Pharmaceuticals’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Petros Pharmaceuticals (PTPI) going to split?
A

There is no upcoming split for Petros Pharmaceuticals.

Q
What sector and industry does Petros Pharmaceuticals (PTPI) operate in?
A

Petros Pharmaceuticals is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.